WVSHP Logo Contact Information
News & Events

News from WVSHP

POCT Certificate Program

The University of Charleston School of Pharmacy will host a pharmacist training session on May 11th from 1-5 PM.  The program will provide the “Community Pharmacy-Based Point-of-Care Testing (POCT) Certificate Program” through the NACDS organization.
 
Specifics from NACDS include:
-Practical, hands-on training in point-of-care testing in four (4) disease states
-20 credit hours of ACPE-accredited continuing education
-Unique dual home study and in-person structure
-Access to and training on the interactive, web-based education platform
 
The cost will be:
    $400 for pharmacists
    $300 for UC alumni and preceptors
    $250 for any current UCSOP students
 
Contact Gannett Monk with any questions at gannettmonk@ucwv.edu, or to request the UC alumni/preceptor/student discount code.
 
To sign up, go to:  http://www.ucwv.edu/POCT/ 

 

ASHP and ACPE revised guidelines ASHP and the Accreditation Council for Pharmacy Education (ACPE) just released revisions to the Accreditation Standards for Pharmacy Technician Educat (Click for more...)

News from elsewhere...
Animal experiment stats show reluctance to embrace modern tools 7/19/2019 8:00:12 AM A shockingly high number of dogs, mice, cats, rabbits and other animals are still suffering in invasive, painful and sometimes lethal experiments in British laboratories. (Click for more...) Bayer, BMS, Ono team up to investigate Stivarga, Opdivo combo 7/19/2019 7:55:02 AM Encouraging early data have been seen with the studied combination, as in a Phase Ib investigator sponsored trial from Japan called REGONIVO (Click for more...) Robots to help produce new class of antibiotics 7/19/2019 7:47:37 AM The antibiotics, known as class II polyketides, are also naturally produced by soil bacteria and have antimicrobial properties. (Click for more...) Boehringer expands IPF pipeline with addition of BBT-877 7/19/2019 7:38:10 AM Under the terms of the deal Bridge Biotherapeutics will receive upfront and near term payments of EUR 45million and is eligible to receive up to more than EUR 1.1billion in potential payments. (Click for more...) Mallinckrodt halts mid-stage Acthar trial citing pneumonia risk 7/19/2019 7:28:31 AM ALS is a progressive neurodegenerative disease that affects motor neuron cells in the brain and the spinal cord. (Click for more...) Novartis’ sickle cell drug wins FDA priority review 7/18/2019 5:40:30 AM The governing body accepted the company's Biologics License Application for prevention of vaso-occlusive crises. (Click for more...) Gender imbalance expected in senior pharma roles until 2090 7/18/2019 5:27:51 AM More than 85% of companies have no women executives on their main boards, only 9% of executive directors on main boards are women, and a mere 17% of FTSE350 executive committee members are women. (Click for more...) Boots UK to offer cystitis test 7/18/2019 5:20:51 AM During the pilot over the last seven months over 1,000 customers accessed the service, with the majority of them completing the service in the same day. (Click for more...) ‘World’s most accurate blood test’ for prostate cancer launched in UK 7/18/2019 5:12:29 AM The Mitomic Prostate Test has a 92% sensitivity, which means that men with a positive result can be referred for immediate medical intervention. (Click for more...) PureTech acquires LYT-100 to treat lymphedema 7/17/2019 7:18:22 AM The candidate, LYT-100, demonstrated anti-fibrotic and anti-inflammatory mechanisms in pre-clinical studies. (Click for more...) Boehringer enriches cancer immunology portfolio with AMAL Therapeutics acquisition 7/17/2019 7:09:46 AM AMAL’s lead vaccine, ATP128, is currently developed for stage IV colorectal cancer and is slated to begin first-in-human trials later this month. (Click for more...) Roche’s Genentech inks deal with Sosei Heptares 7/17/2019 7:02:11 AM Under the terms of the agreement, Sosei Heptares is eligible to receive US$26 million in upfront and near-term payments. (Click for more...) NICE U-turn for Kisqali in breast cancer 7/17/2019 6:49:31 AM NICE has recommended Novartis’ Kisqali just three months after its initial rejection. (Click for more...) Pistoia Alliance launches FAIR implementation ‘toolkit’ 7/17/2019 6:41:15 AM The ‘toolkit’, will be available to help companies implement the FAIR guiding principles for data management and stewardship. (Click for more...) NHS rolls out staff retention scheme 7/16/2019 5:02:58 AM A new ‘transfer window’ lets staff move within the NHS between areas while developing new skills. (Click for more...)
 
Copyright© 2019 West Virginia Society of Health System Pharmacists. All rights reserved.

Updating...